Disc Medicine, Inc.
IRON
$38.73
$3.509.94%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 36.42% | 80.02% | 40.91% | 56.89% | 42.84% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.28% | 73.31% | 78.05% | 25.22% | 97.82% |
| Operating Income | -16.28% | -73.31% | -78.05% | -25.22% | -97.82% |
| Income Before Tax | -24.35% | -87.81% | -65.12% | -18.39% | -109.42% |
| Income Tax Expenses | 450.00% | 470.00% | 150.00% | -78.26% | -- |
| Earnings from Continuing Operations | -24.93% | -88.35% | -65.25% | -18.30% | -109.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.93% | -88.35% | -65.25% | -18.30% | -109.70% |
| EBIT | -16.28% | -73.31% | -78.05% | -25.22% | -97.82% |
| EBITDA | -16.34% | -73.48% | -77.67% | -25.24% | -97.98% |
| EPS Basic | -1.82% | -52.98% | -38.43% | 9.63% | 88.60% |
| Normalized Basic EPS | 4.72% | -52.55% | -52.69% | 9.54% | 87.89% |
| EPS Diluted | -1.82% | -52.98% | -38.43% | 9.63% | 88.60% |
| Normalized Diluted EPS | 4.72% | -52.55% | -52.69% | 9.54% | 87.89% |
| Average Basic Shares Outstanding | 22.69% | 23.11% | 19.38% | 30.89% | 1,739.85% |
| Average Diluted Shares Outstanding | 22.69% | 23.11% | 19.38% | 30.89% | 1,739.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
